BONESUPPORT’s FDA notification: Approval on DeNovo pathway for CERAMENT G will require additional data and clarifications

27th February 2021

Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

26th February 2021

Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

30th December 2020

Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

30th December 2020

Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

5th November 2020

NOTICE OF ANNUAL SHAREHOLDERS’ MEETING IN BONESUPPORT HOLDING AB

21st October 2020

BULLETIN FROM THE ANNUAL SHAREHOLDERS’ MEETING IN BONESUPPORT HOLDING AB ON 22 MAY 2018

21st October 2020

BONESUPPORT™ Raises $37 Million (SEK 327 million) to Drive Product Sales and Deliver Further Value From CERAMENT® Injectable Drug Eluting Bioceramic Platform

20th October 2020

BONESUPPORT HOLDING AB signs an agreement on a working capital facility of SEK 60 million

20th October 2020

Bulletin from the annual shareholders’ meeting in BONESUPPORT HOLDING AB on 19 May 2020

20th October 2020